Project Grant R01DA060156
Award Date
5/15/25
Completion Date
2/28/30
Dollars Obligated
$589K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $668,110 to Washington State University to refine and assess the feasibility and acceptability of a technology-based intervention to increase college students' awareness of cannabis products, laws, and associated risks. The study aims to educate the nearly 7 million undergraduate students enrolled in states that have legalized recreational cannabis...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will explore the neurobehavioral effects of concurrent opioid and methamphetamine use disorders. The $223,715 award, effective from July 2024 through February 2027, will support research conducted by the University of Washington to: Define the behavioral patterns and motivations underlying polysubstance addiction using a rodent self-administration...
This Project Grant award of $1,362,860 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study on the co-use of cannabis and prescription opioids among emerging adults in medical settings. The study aims to identify individual risk factors and malleable protective factors that contribute to the development of opioid and cannabis co-use and related problems in the context of pain management. The research will...
The National Institute on Drug Abuse (NIDA) awarded a $2,427,126 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Washington State University. The grant, titled "Strength in Healing: Indigenous Community-Led Strategies to Treat Stimulant Use", aims to rapidly implement culturally responsive interventions for stimulant use disorders among American Indian and Alaska Native (AI/AN) populations, who experience disproportionately high rates of fatal...
This National Institute on Drug Abuse (NIDA) award under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $311,000 to the University of Washington to develop and pilot test a mobile health intervention to reduce frequent and high-intensity cannabis use among non-college young adults. The proposed "TAKE 5" intervention will integrate online personalized feedback and tailored text messages to address patterns of use, motivations, social influences, personal goals,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to assess the acceptability and feasibility of using pharmacogenomic (PGx) testing to guide opioid use disorder (OUD) treatment. The $195,728 award, effective January 1, 2025 through December 31, 2029, will support the following key activities: Identifying barriers and facilitators to the acceptability and feasibility of a PGx testing...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This federal Project Grant award for $1,702,558.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on optimizing an online behavioral intervention to prevent and reduce substance use among high school seniors during a critical transition period. The overarching objective is to design, evaluate, and refine a scalable, evidence-based online intervention that targets social influences linked to substance use,...
The federal Project Grant award of $360,100.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project, awarded to George Washington University, aims to advance scientific understanding of cannabis and derived cannabis product use patterns and...
The National Institute on Drug Abuse (NIDA) awarded a $483,056 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School to conduct research on the mechanisms linking opioid addiction, sleep, and circadian rhythms. The primary goals are to investigate the roles of the circadian transcription factor NPAS2 and dopamine D3 receptor signaling in the nucleus accumbens in controlling opioid craving and relapse behaviors. The...